HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
POLE3
DNA polymerase epsilon 3, accessory subunit
Chromosome 9 · 9q32
NCBI Gene: 54107Ensembl: ENSG00000148229.14HGNC: HGNC:13546UniProt: Q9NRF9
59PubMed Papers
20Diseases
7Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
CLINICAL
FDA Approved Target
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
regulation of DNA replicationnucleosome assemblychromatin remodelingATAC complexacute lymphoblastic leukemiaacute myeloid leukemianon-small cell lung carcinomachronic lymphocytic leukemia
✦AI Summary

POLE3 is an accessory subunit of DNA polymerase epsilon (Polε) that plays multifaceted roles in replication, chr9 maintenance, and transcriptional silencing. As a histone H3-H4 chaperone, POLE3-POLE4 promotes nucleosome assembly during DNA replication and facilitates coordinated parental histone retention and new histone deposition 1. POLE3 functions in replication-coupled chr9 integrity by binding histones and promoting tetrasome formation 1. Beyond replication, POLE3 contributes to heterochromatin maintenance by interacting with the HUSH complex to promote asymmetric H3K9me3 distribution at head-on LINE elements, suppressing their expression during S phase 2. POLE3 maintains repressive chr9 at unintegrated HIV-1 DNA, preventing RNA polymerase II recruitment and facilitating viral escape from innate immunity while enabling efficient integration 3. Loss of POLE3-POLE4 causes replicative gap accumulation upon PARP inhibitor treatment through impaired post-replicative repair, sensitizing cells to these agents 45. POLE3 also participates in sister chr9 cohesion in parallel to other replication factors 6. These findings establish POLE3 as a critical regulator of leading strand synthesis integrity and suggest targeting POLE3 may enhance chemosensitization 78.

Sources cited
1
POLE3-POLE4 functions as histone H3-H4 chaperone promoting nucleosome assembly and maintaining chromatin integrity during DNA replication
PMID: 30217558
2
POLE3 interacts with HUSH complex and leading-strand Polε to promote asymmetric H3K9me3 distribution and silence LINE elements in S phase
PMID: 37938774
3
POLE3 represses unintegrated HIV-1 DNA transcription by maintaining repressive chromatin, facilitating viral integration and escape from innate immunity
PMID: 37922361
4
Loss of POLE3-POLE4 causes replicative gap accumulation upon PARP inhibitor treatment, sensitizing cells through impaired post-replicative repair
PMID: 38753485
5
POLE4 loss affects replication speed and leads to accumulation of single-stranded DNA gaps, causing BRCA1-independent PARP inhibitor sensitivity
PMID: 38828775
6
POLE3 contributes to sister chromatid cohesion in pathways parallel to DSCC1-RFC during DNA replication
PMID: 36622344
7
POLE3 is a cellular target of small molecule inhibitors that may serve as chemosensitization strategy to DNA damaging drugs
PMID: 30461272
8
POLE3-POLE4 regulates leading strand synthesis through DNA processivity gripping, requiring iron metabolism genes for ISC-dependent Polε activity
PMID: 41339636
Disease Associationsⓘ20
acute lymphoblastic leukemiaOpen Targets
0.59Moderate
acute myeloid leukemiaOpen Targets
0.59Moderate
non-small cell lung carcinomaOpen Targets
0.59Moderate
chronic lymphocytic leukemiaOpen Targets
0.59Moderate
pancreatic carcinomaOpen Targets
0.58Moderate
neoplasmOpen Targets
0.56Moderate
breast carcinomaOpen Targets
0.54Moderate
ovarian carcinomaOpen Targets
0.54Moderate
breast cancerOpen Targets
0.53Moderate
ovarian cancerOpen Targets
0.52Moderate
myelodysplastic syndromeOpen Targets
0.51Moderate
neurodegenerative diseaseOpen Targets
0.47Moderate
leptomeningeal metastasisOpen Targets
0.45Moderate
cancerOpen Targets
0.43Moderate
lymphomaOpen Targets
0.42Moderate
leukemiaOpen Targets
0.42Moderate
nasopharyngeal carcinomaOpen Targets
0.42Moderate
lung cancerOpen Targets
0.42Moderate
urinary bladder cancerOpen Targets
0.41Moderate
diffuse large B-cell lymphomaOpen Targets
0.41Moderate
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets7
ASPACYTARABINEPhase II
DNA polymerase (alpha/delta/epsilon) inhibitor
acute myeloid leukemia by FAB classification
CLOFARABINEApproved
DNA polymerase (alpha/delta/epsilon) inhibitor
acute lymphoblastic leukemia
CYTARABINEApproved
DNA polymerase (alpha/delta/epsilon) inhibitor
acute lymphoblastic leukemia
FLUDARABINE PHOSPHATEApproved
DNA polymerase (alpha/delta/epsilon) inhibitor
GEMCITABINEApproved
DNA polymerase (alpha/delta/epsilon) inhibitor
GEMCITABINE HYDROCHLORIDEApproved
DNA polymerase (alpha/delta/epsilon) inhibitor
breast carcinoma
TROXACITABINEPhase II
DNA polymerase (alpha/delta/epsilon) inhibitor
Related Genes
POLGProtein interaction100%REV3LProtein interaction100%SMARCA1Protein interaction100%BAZ1BProtein interaction100%MAD2L2Protein interaction100%BAZ2AProtein interaction100%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
57%
Heart
31%
Lung
31%
Liver
28%
Ovary
21%
Gene Interaction Network
Click a node to explore
POLE3POLGREV3LSMARCA1BAZ1BMAD2L2BAZ2A
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q9NRF9
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.15LoF Tolerant
pLIⓘ
0.01Tolerant
Observed/Expected LoF0.64 [0.37–1.15]
RankingsWhere POLE3 stands among ~20K protein-coding genes
  • #7,802of 20,598
    Most Researched59
  • #317of 1,025
    FDA-Approved Drug Targets5
  • #11,980of 17,882
    Most Constrained (LOEUF)1.15
Genes detectedPOLE3
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Asymmetric distribution of parental H3K9me3 in S phase silences L1 elements.
PMID: 37938774
Nature · 2023
1.00
2
POLE3 is a repressor of unintegrated HIV-1 DNA required for efficient virus integration and escape from innate immune sensing.
PMID: 37922361
Sci Adv · 2023
0.90
3
Loss of POLE3-POLE4 unleashes replicative gap accumulation upon treatment with PARP inhibitors.
PMID: 38753485
Cell Rep · 2024
0.80
4
Total Synthesis, Biological Evaluation, and Target Identification of Rare Abies Sesquiterpenoids.
PMID: 30461272
J Am Chem Soc · 2018
0.70
5
The loss of DNA polymerase epsilon accessory subunits POLE3-POLE4 leads to BRCA1-independent PARP inhibitor sensitivity.
PMID: 38828775
Nucleic Acids Res · 2024
0.60